DOCSLIB.ORG

Hospital Pharmacy SCIENCE and PRACTICE EUROPEAN JOURNAL of HOSPITAL PHARMACY

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hospital Pharmacy SCIENCE and PRACTICE EUROPEAN JOURNAL of HOSPITAL PHARMACY 21 March 2014 Volume 21 Supplement 1 S1 European Journal of Volume 21 Volume Supplement 1 A1–A224 Pages Hospital Pharmacy SCIENCE AND PRACTICE EUROPEAN JOURNAL OF HOSPITAL PHARMACY OF HOSPITAL JOURNAL EUROPEAN ABSTRACT BOOK 19th Congress of the EAHP 26-28 March 2014, Barcelona, Spain March 2014 March ejhp.bmj.com EJHP: Science and Practice The official journal of the European The European Journal of Hospital Pharmacy: Association of Hospital Pharmacists (EAHP) Science and Practice offers a high-quality, peer- Editor in Chief Phil Wiffen (UK) reviewed platform for the publication of practical [email protected] Deputy Editor and innovative research and aims to strengthen the Tommy Eriksson (Sweden) [email protected] profile and professional status of European hospital Editors V’lain Fenton-May (UK) pharmacists [email protected] Per Hartvig Honoré (Denmark) International Advisory Board Members [email protected] Contact Details Associate Editors Mike Allwood (UK) Mirjana Gasperlin (Slovenia) Editorial Office Ilko Getov (Bulgaria) [email protected] Jo-Anne Brien (Australia) Robert Janknegt (Netherlands) EJHP Science and Practice Editorial Office, Jean-Daniel Hecq (Belgium) Damian Child (UK) Lene Juel Kjeldsen (Denmark) BMA House, Tavistock Square, London, [email protected] Moses S S Chow (USA) Mark Stuart (UK) WC1H 9JR, UK Ana Herranz (Spain) T: +44 (0)20 7383 6622 Lona Christrup (Denmark) Helmut Viernstein (Austria) [email protected] E: [email protected] Catherine Mooney (UK) George Dranitsaris (Canada) Vesna Vrca-Bacic (Croatia) [email protected] Permissions Stefan Mühlebach (Switzerland) http://journals.bmj.com/misc/permissions.dtl [email protected] Piera Polidori (Italy) Guidelines for Authors and Reviewers Production Editor [email protected] Full instructions are available online at http://ejhp.bmj. com/ Malcolm Smith Gunar Stemer (Austria) site/about/guidelines.xhtml. Articles must be [email protected] [email protected] Juraj Sykora (Slovakia) submitted electronically http://mc.manuscriptcentral.com/ Supplement Enquiries [email protected] ejhpharm. Authors are required to transfer copyright in their T: +44 (0)20 7383 6795 Steve Williams (UK) work to the European Association of Hospital Pharmacists E: [email protected] [email protected] http://group.bmj.com/products/journals/instructions- Subscriptions Disclaimer for-authors/licence-forms While every effort is made by publishers T: +44 (0)20 7111 1105 and editorial board to see that no Impact factor: 0.110 E: [email protected] inaccurate or misleading data, opinions, or statements appear in this Journal, Display Advertising Sales they wish to make it clear that the data Included in Science Citation Index. and opinions appearing in the articles and Sophie Fitzsimmons (Sales Manager) advertisements herein are the responsibility T: +44 (0)20 7383 6783 of the contributor or advertiser concerned. E: sfi[email protected] Accordingly, the publishers and the http://group.bmj.com/group/advertising the European Association of Hospital Pharmacists (EAHP), the editorial Online Advertising Sales committee and their respective employees, offi cers and agents, accept no Marc Clifford (Sales Manager) liability whatsoever for the consequences T: +44 (0) 20 7383 6161 of any such inaccurate or misleading data, E: [email protected] opinion or statement. While every effort http://group.bmj.com/group/advertising is made to ensure that drug doses and Subscription Information other quantities are presented accurately, readers are advised that new methods Display & Online Advertising Sales and techniques involving drug usage, EJHP: Science and Practice is published bimonthly (USA) described within this Journal, should only (subscribers receive all supplements) Jim Cunningham be followed in conjunction with the drug manu facturer’s own published literature. T: +1 201 767 4170 Institutional Rates Personal Rates 2014 E: [email protected] Copyright: © 2014 The European Association of Hospital Pharmacists 2014 Print (includes online access (EAHP). All rights reserved; no part of this Author Reprints publication may be reproduced, stored in a Print and online at no additional cost) Reprint Administrator retrieval system or transmitted in any form £175; 237; $342 T: +44 (0)20 7383 6305 or by any means, electronic, mechanical, £515; 696; $1005 (small) E: [email protected] photocopying, recording or otherwise £626; 846; $1221 (medium) Online only without prior permission. £154; 208; $301 Commercial Reprints The European Journal of Hospital £700; 945; $1365 (large) Pharmacy: Science and Practice (EJHP Online only (except USA & Canada) Science and Practice) is published Nadia Gurney-Randall bimonthly by BMJ Publishing Group Ltd, £446; 603; $870 (small) T: +44 (0)20 8445 5825 and printed in the UK on acid-free paper from sustainable forests. £562; 759; $1096 (medium) M: 07866 262344 The European Journal of Hospital £636; 859; $1241 (large) E: [email protected] Pharmacy: Science and Practice (EJHP Science and Practice) (ISSN No: ISSN 2047-9956 (print), 2047-9964 (online) Commercial Reprints (USA & Canada) 2047-9956) is distributed in the USA Personal print or online only and institutional print subscriptions may Marsha Fogler by Air Business Ltd. Periodicals postage paid at Jamaica NY 11431. POSTMASTER: be purchased online at http://group.bmj.com/group/subs-sales/ T: +1 800 482 1450 (toll free in the USA) send address changes to The European subscriptions (payment by Mastercard/Visa only). T: +1 856 489 4446 (outside the USA) Journal of Hospital Pharmacy: Science and E: [email protected] Practice, Air Business Ltd, c/o Worldnet Residents of some EC countries must pay VAT; for details, call us or visit Shipping Inc., 156-15, 146th Avenue, www.bmj.com/subscriptions/vatandpaymentinfo.dtl 2nd Floor, Jamaica, NY 11434, USA. Contents Volume 21 Supplement 1 | EAHP March 2014 Abstracts from the EAHP 2014 Congress A1 Clinical Pharmacy A136 Pharmacokinetics and Pharmacodynamics A63 Drug Distribution A144 Patient Safety and Risk Management A70 Drug Information and Pharmacotherapy A185 Other Hospital Pharmacy Topics A113 General Management A208 International Posters A122 Production and Preparation A213 Author index POSTER AWARD NOMINEES Presentations on Wednesday, March 26th, 14:00–15:30, Room 117 Time Poster number Poster nominee oral presentations Author(s) 14:00 PKP-015 Optimal dose regimen of antibiotics against methicillin- D. Soy Muner resistant Staphylococcus aureus in critically ill patients undergoing continuous venovenous hemodiafiltration 14:15 OHP-018 CE marking for implantable medical devices: what’s going M. Dupres on behind the doors hospital? 14:30 OHP-006 Electronic prescribing and robotic dispensing: the need R. Beard for a taxonomy to compare research papers 14:45 GM-007 Clinical pharmacy services in cardiology: a lean N. Curatolo perspective analysis 15:00 PKP-011 Pharmacokinetics of everolimus in combination with N. Oliveira mycophenolate sodium and clinical outcomes in renal transplant recipients previously treated with calcineurin inhibitors 15:15 DI-040 Risk of assessment bias of systematic reviews that study J. González-Bueno interventions to improve medicines adherence in polypathological patients Presentations on Thursday, March 27th, 08:30–10:00, Room 117 Time Poster number Poster nominee oral presentations Author(s) 8:30 CP-118 Neonatal vancomycin: exploring levels at NHS Tayside, A. Tonna Scotland 8:45 PS-058 Initiative to contact patients: social media in a hospital M. Mejía pharmacist department 9:00 PS-062 To what extent is information used to perform C. Mestres Gonzalvo medicines reviews? 9:15 PS-095 European survey on the implementation of standardized S. Senhaji concentrations for drug infusion in pediatric and neonatal intensive care 9:30 PKP-005 Influence of ERB2 ile655val polymorphism on trastu- C. Gómez Peña zumab-induced cardiotoxicity in HER2 positive breast cancer women 9:45 CP-131 Analysis of the efficiency of pharmaceutical care in an I. Sánchez-Quiles Emergency Service Thinking About Stroke Prevention in AF? Think Xarelto®: One Tablet, Once-Dailya,1,2 a Xarelto® is licensed for prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors. AF = atrial fibrillation. Xarelto 10 mg / 15 mg / 20 mg film-coated tablets in patients receiving concomitant systemic treatment with strong concurrent haemorrhage (menorrhagia very common in women < 55 years treated for (Refer to full SmPC before prescribing) CYP3A4- and P-gp-inhibitors, i.e. azole-antimycotics or HIV protease inhibitors; DVT, PE or prevention of recurrence), renal impairment, fever, peripheral in patients with increased bleeding risk; in patients receiving concomitant oedema, decreased general strength and energy, increase in transaminases, This medicinal product is subject to additional monitoring. treatment with strong CYP3A4 inducers unless the patient is closely observed post-procedural haemorrhage, contusion, wound secretion. Uncommon: for signs and symptoms of thrombosis; not recommended due to lack of thrombocythemia, allergic reaction, dermatitis allergic, cerebral and intracranial Composition: Active ingredient: 10 mg / 15 mg / 20 mg rivaroxaban. Excipients: data: in patients below 18 years of age, in patients concomitantly treated haemorrhage, syncope, tachycardia, dry mouth, hepatic function abnormal, Microcrystalline cellulose, croscarmellose
Load more

Recommended publications
  • •Prescription Review •Medication Review
    THE USE OF CLINICAL PHARMACISTS AND PHARMACONOMIST SERVICES IN REGARDS TO RESOURCE CONSUMPTION AND MEDICATION SAFETY IN A DANISH HOSPITAL SETTING Laura Victoria Moesgaard Lech, stud.pharm, School of Pharmaceutical Sciences, Trine Rune Høgh Nielsen, cand.pharm, ph.d., Region Zealand Hospital Pharmacy, Lona Louring Christrup, cand.pharm. ph.d., School of Pharmaceutical Sciences. Denmark. BACKGROUND RESULTS Drug-Related Problems (DRPs) are factors for increased Over the course of three weeks, 157 patients were included. morbidity, mortality and costs in the health-care system. Preventing, Number of DRPs: In total, 515 DRPs were identified (bar chart). identifying and solving DRPs are therefore essential for the There was no significant statistic difference between the number of medication safety in hospital settings. Two approaches for this are DRPs identified by PMM and CPS (Mann-Whitney, p> 0.05). the use of clinical pharmacists (MSc in pharmaceuticals and post graduate courses) and pharmaconomists (3-year education in Type of DRPs: The most frequent problem in PMM and CPS were pharmaceuticals). “costs-effectiveness” and “treatment effectiveness”, respectively, accounting for more than half of all DRPs. The type of DRPs were AIM statistically significant between across all groups (χ2, p<0.05). To investigate the number, type and severity of DRPs identified by Pharmaconomist Medication Management (PMM) and Clinical Pharmacist Service (CPS), respectively. Severity: The distribution of the severity of the DRPs across the To assess the resource consumption per patient for the PMM and three groups are shown in the bar chart. The distribution of severity 2 the CPS, respectively. was significantly different across all groups (χ , p<0.05).
    [Show full text]
  • QA Coordinator in a Biotech Company Focused on the Discovery, Design and Development of Innovative Peptide-Based Medicines
    Join us for a better future Be the new QA Coordinator in a biotech company focused on the discovery, design and development of innovative peptide-based medicines Zealand Pharma A/S (Zealand) aims to become a fully integrated biotechnology company leading in delivery of specialty medicines. We are passionate about improving the quality of life for patients with metabolic and gastrointestinal diseases, and other specialty or rare disease areas with significant unmet medical needs. In the QA team, we are now looking for a new colleague to help us build and maintain the structure in our quality system and to secure follow-up activities. The position will report to VP Quality. Ensure tracking and timely follow-up on quality related documentation hereunder deviations, change controls, audits and batch related documentation Maintain and track updates to Zealand’s Quality Management System Become superuser of the Quality Module in our validated electronic system, covering change management, deviation and CAPA management and audit & vendor management Become the QA superuser of Zealand’s EDMS system Ensure routine KPI reporting to management on training, SOP finalization, and relevant Quality topics Be an active part of records management and data governance in QA Assist in the planning and follow-up of the quality audit program Managing the Quality Management Review – drive the process, compile data and prepare for routine QMR including documentation and follow-up Prepare relevant batch related documentation in connection with release. Job Profile The successful candidate will be: Pragmatic and yet with a compliant quality mindset Have high standards for ethics and integrity High degree of structural skills and ability to transform them to practical solutions Strong communication skills verbally as well as in writing Energy and drive for team results, consistent high-performer Ability to work effectively in a fast-paced environment Enjoy being in a great team and achieve things together Fluent in English (company language) and Danish.
    [Show full text]
  • LECTURE NOTES on BP 703T. PHARMACY PRACTICE
    LECTURE NOTES on BP 703T. PHARMACY PRACTICE (Theory) Unit IV a) BUDGET PREPARATION AND IMPLEMENTATION Budget preparation and its implementation are one of the important tasks of the pharmacy department of any hospital. It requires several factors into consideration like planning & strategy for maintenance and development etc. The word budget means the financial plan of a hospital for the period of a year. Budget is a quantity of plan of action and aid to the coordination and implementation of plan. DEFINITION:- Budget is described as an instrument through which hospital administration, management at the department levels and the governing bodies can review the hospital services in relationship to the prepared plan in a comprehensive and integrated form expressed in financial terms. OBJECTIVES: a) Development of standards b) Comparison of actual results with standards c) Identification of deviation or fluctuation d) Analysis of deviation e) The responsible person will use the budget f) Details to determine whether the proposal is economically feasible and realistic. g) To monitor the hospital financial activities. h) Estimate the cost of completing objectives identified in the proposal. ADVANTAGES OF PLANNING THE BUDGET: a) Develop better financial planning. b) Gives a better focus on decision making to the management. c) Effectively manage the financial aspects of the hospital d) Exposes the reasons of over expenditure e) Helps to focus on hospital priorities f) Enhance efficiency of staffs and others TYPES OF BUDGET PREPARATION: Based on the duration of budget, it can be divided in to: Short term budget (2 years) Long term budget (5 - 10 years) DIVISION OF BUDGETS: 1.
    [Show full text]
  • Pharmaceutical Interventions on Prescription Problems in a Danish Pharmacy Setting
    Int J Clin Pharm DOI 10.1007/s11096-011-9580-4 RESEARCH ARTICLE Pharmaceutical interventions on prescription problems in a Danish pharmacy setting Anton Pottega˚rd • Jesper Hallas • Jens Søndergaard Received: 29 June 2011 / Accepted: 29 October 2011 Ó Springer Science+Business Media B.V. 2011 Abstract Background International studies regarding (9.4–11.1) interventions per 1,000 prescriptions. Conclusion pharmacists’ interventions towards prescription problems We found an intervention rate substantially higher than produce highly variable results. The only peer-reviewed study reported in previous Danish studies. in a Danish setting estimated an intervention rate of 2.3 per 1,000 prescriptions. With the introduction of a new tool for Keywords Clinical pharmacy Á Denmark Á Pharmacy registration, we hypothesized that a better estimate could be practice Á Primary care Á Problem prescriptions Á obtained. Objective We aimed to produce an up-to-date Pharmacists’ interventions estimate of the extent and type of pharmacists’ interventions towards prescription problems in a Danish pharmacy setting Setting The study was conducted at Copenhagen Sønderbro Impact of findings on practice Pharmacy, a large urban 24-hour pharmacy. Method Data were collected prospectively through an electronic form. All • The number of interventions on prescriptions in Danish interventions were primarily classified as either clinical or community pharmacies, is probably significantly higher administrative in nature, and further classified in a number of than older studies indicated. pre-determined subcategories. Furthermore, information • One third of the interventions in Danish pharmacies are about age, sex, time of day, the wording of the prescription, have a clinical background. the performed intervention, the person performing the inter- • Community pharmacists in Denmark intervene mostly vention and the type of prescriber were recorded.
    [Show full text]
  • Public Health and Patient Care Aspects in Pharmacy Education and Pharmacists’ Role in National Public Health Programs in India
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Helsingin yliopiston digitaalinen arkisto Clinical Pharmacy Group: Social Pharmacy Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy University of Helsinki Public Health and Patient Care Aspects in Pharmacy Education and Pharmacists’ Role in National Public Health Programs in India Siva Prasada Reddy Maddirala Venkata ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Pharmacy of the University of Helsinki, for public examination in Auditorium Athena, Siltavuorenpenger 3 A, on Friday 19 May 2017, at 12 noon. Helsinki 2017 Supervisors Professor Marja Airaksinen, PhD Clinical Pharmacy Group: Social Pharmacy Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy, University of Helsinki Helsinki, Finland Proprietor Pharmacist Peter Kielgast, PhD Taastrup Pharmacy Taastrup Hovedgade 60 2630 Taastrup, Denmark Pre-examiners Professor B. Suresh Vice-Chancellor, Jagadguru Sri Shivarathreeshwara University and President, Pharmacy Council of India JSS Medical Institutions Campus Sri Shivarathreeshwara Nagara Mysuru – 570 015, Karnataka, India Dr. T. V. Narayana Director, Vikas Institute of Pharmaceutical Sciences Nidigatla village, Korukonda Mandal, Near Airport Rajahmundry, East Godavari Dist Andhra Pradesh – 533103, India Opponent Fernando Fernandez-Llimos, Ph.D., PharmD., M.B.A. Assistant Professor, Department of Social Pharmacy University of Lisbon, Portugal © Siva Prasada Reddy Maddirala Venkata 2017 ISBN 978-951-51-3169-0 (paperback) ISBN 978-951-51-3170-6 (PDF) Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis Helsinkiensis ISSN 2342-3161 (print) ISSN 2342-317x (online) University of Helsinki, Finland 2017 ABSTRACT Pharmacies are convenient for most people to get to and there is no need for an appointment to see pharmacist which makes them natural first port of call1 healthcare providers in the society.
    [Show full text]
  • Global Journal of Medical Research: B Pharma, Drug Discovery, Toxicology & Medicine
    Online ISSN : 2249-4618 Print ISSN : 0975-5888 DOI : 10.17406/GJMRA DrugComplianceamongPeople AntidiabeticHerbalCapsule TypesofMachineryofTranscription ADetailedReviewonPlantMaterial VOLUME21ISSUE2VERSION1.0.0 Global Journal of Medical Research: B Pharma, Drug Discovery, Toxicology & Medicine Globa l Journal of Medical Research: B Pharma, Drug Discovery, Toxicology & Medicine Volume 2 1 Issue 2 (Ver. 1.0) Open Association of Research Society Global Journals Inc. © Global Journal of Medical (A Delaware USA Incorporation with “Good Standing”; Reg. Number: 0423089) Sponsors:Open Association of Research Society Research. 2021. Open Scientific Standards All rights reserved. Publisher’s Headquarters office This is a special issue published in version 1.0 of “Global Journal of Medical Research.” By ® Global Journals Inc. Global Journals Headquarters 945th Concord Streets, All articles are open access articles distributed under “Global Journal of Medical Research” Framingham Massachusetts Pin: 01701, United States of America Reading License, which permits restricted use. Entire contents are copyright by of “Global USA Toll Free: +001-888-839-7392 Journal of Medical Research” unless USA Toll Free Fax: +001-888-839-7392 otherwise noted on specific articles. Offset Typesetting No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including Global Journals Incorporated photocopy, recording, or any information 2nd, Lansdowne, Lansdowne Rd., Croydon-Surrey, storage and retrieval system, without written permission. Pin: CR9 2ER, United Kingdom The opinions and statements made in this Packaging & Continental Dispatching book are those of the authors concerned. Ultraculture has not verified and neither confirms nor denies any of the foregoing and Global Journals Pvt Ltd no warranty or fitness is implied.
    [Show full text]
  • Region Sjælland
    Identification of DRPs by pharmacists and pharmaconomists performing two types of medication reviews in a Danish hospital setting Oral Communication – 5th PCNE Working Symposium 2016, Hillerød, Denmark Trine R. H. Nielsen Thank you to Laura V. M. Lech The Danish hospital pharmaconomist • Pharmaconomists have a 3-year trainee education in pharmaceuticals and health care. • Region Zealand Hospital Pharmacy has 2,5 pharmaconomist per clinical pharmacist. • Pharmaconomists perform medication management (PMM) daily on all bed units. • PMM consists of top-up service, logistics and prescription reviews. • Prescription review is defined as: A technical review of each drug prescription with focus on prescribing and dispensing within the hospital formulary*. • Each pharmaconomist perform 50-100 prescription review each day. * Kjeldsen, LJ. et al (2014). Ugeskrift for laeger, 176(24). Purpose How many and what kind of DRPs are identified during the daily prescription reviews? How are these DRPs compared to a clinical pharmacist medication review? Method - Setting Næstved Hospital: • Rural non-university hospital with 11 departments and 38 wards (bed-units and out-patient clinics) • The 14 bed-units were invited to participate • 8 bedunits participated in the 3-week study • Each unit received an Clinical Pharmacist Service for 1 week. Participants: • Adults • All newly admitted patients • Had one or more prescriptions Method - Intervention Pharmaconomist Medicine Management Prescription Review PCNE Type 1 Clinical Pharmacist Service Medication Review PCNE Type 2b Baseline Review PCNE “Type 1” (PCNE workshop 2013) Method – Intervention tools The different reviews was made on the same group of patients simultaneously, but separately. RDTC: Regional Drug and Therapeutics Committee Method – Outcome measure • Number of DRPs In total and per patient • Type of DRPs Using the PCNE DRP Classification V6.2 • Severity of DRPs Using a classification ranging from S.1 (serious adverse events) to S.5 (unlikely to affect the patient)* *Dutton, Karen, et al.
    [Show full text]
  • The Community Pharmacy Advising COPD Patients About Medical
    The Community Pharmacy advising COPD patients about medical nutrition by Theresia Treschow-Kühl, Pharmaconomist, Master of Divinity & Master of Education and HR Aabenraa Løve Apotek, Aabenraa, Denmark Conclusion: Introduction: Weight loss: The weight loss was prevalent in the survey, was the expected In Denmark it is estimated 320.000 Danes have COPD, but only about 50 % result - but it was not! The information and knowledge about COPD should have been diagnosed. The Danish population is 5,6 million, it is a stagger- have given a result in the survey, that most of the costumers would have ing 7,5 % of the population suffer from COPD. In Denmark about 300.000 experiences a loss og weight. But loss og weight was not prevalent in the suffer from astma which is 7 % of the Danish population (The Danish Soci- survey - only 30 % of the costumers had lost weight, and 25 % had actu- ety of Lung disease). ally gained weight. In Denmark we have a strategy concerning Asthma Inhaling Instruction. The The factors can be many: Danish Board of Health awards the pharmacy a certain payment for every 1. A small survey - costumers are met at the counter, not costumers who Asthma Inhaling Instruction. are more or less housebound. The instructions of Astma Inhaling devizes are used by Astma and COPD 2. The costumers understanding when the loss of weight was an issue. patients, and the pharmacies have a certified advisory scheme concerning 3. Is it the “New normal” that counts when costumers who have been di- the use af Inhaling devizes. The Pharmacy already are in contact with the agnosed with COPD for more than 4 years 9 out of 14 either maintain costumers have established a dialogue with the patients.
    [Show full text]
  • PHARMACISTS International Appeal to Stop 5G on Earth and in Space
    International Appeal to Stop 5G on Earth and in Space PHARMACISTS ALGERIA Ghania Laouar, pharmacy, student at university of BATNA 2 -BATNA-ALGERIA, Batna, Algeria ARGENTINA Fedra Elena Lecumberry, Farmacéutica Nacional, Director Técnico, Rincón de Los Sauces, Neuquén Paula Mora, Pharmacist, Buenos Aires, Buenos Aires Andrea Vaquero , Universitario, Farmacéutico Hospital Tornu, Bolivar, Buenos Aires AUSTRALIA emma collyns, Diploma of Pharmacy, Pharmacist, Minyama, QLD Jeffrey Cox, Batchelor of Pharmacy, Pharmacist, Melbourne, Vicky Taru Crane, Pharmacist, ULLADULLA, NSW Elise Dafinis, Melbourne, Victoria Xaviere Desmet, Sydney, Nsw George Dimaris, Bachelor of Pharmacy, Sydney, New South Wales Didi Hounslow, Walkerville, SA Ana Jezdik, Law, Pharmacy, Perth, Western Australia noel keogh, b.pharmacy univ qld aust; m.pharm studies univ qld aust ; public policy studies kennedy school of govt harvard mass.usa, armidale, new south wales John Laird, Bachelor of Pharmacy, Postgrad study in Nutrition, Psychology, Philosophy and Exercise Physiology, Pharmacist, Gold Coast, Queensland karl landers, BSc.Pharmacy, pharmacy, brookvale, NSW Vicky Melissas, Bachelor of pharmacy, Pharmacist, Melbourne, Victoria Judy Miller, Adelaide, South Australia George Papadopoulos, Kellys Plains John Ralph, Gosford, NSW PATRICK THORNTON, PHARMACIST, NUTRITIONIST, INVENTOR, OAK FLATS, NSW Natalia Varakina, Bachelor of Pharmacy, Sydney Ingrid Waite, Sydney, NSW Jess White, Doonan, Queensland AUSTRIA Susanne Artacker, Mag. pharm., Pharmacist, Vienna Margit Drack, Drogistin,
    [Show full text]
  • Danish Reaction to Challenges When Working in Pharmacies Or Training to Be a Pharmaconomist During COVID-19 Christina Durinck1, Elsebeth Hagen2
    Pharmacy Education (2020) 20(2) 102 - 105 https://doi.org/10.46542/pe.2020.202.102105 COVID-19 SPECIAL COLLECTION EDITORIAL Moving online and keeping a distance: Danish reaction to challenges when working in pharmacies or training to be a pharmaconomist during COVID-19 Christina Durinck1, ElseBeth Hagen2 1The Danish Association of Pharmaconomists, Denmark 2The Pharmacological Association, Denmark Correspondence This article describes the workforce and educational challenges faced by Christina Durinck pharmaconomists in Denmark as a consequence of the first wave of the The Danish Association of Pharmaconomists COVID-19 pandemic. In Danish pharmacies, pharmaconomists make up the Ramsingsvej 30 majority of the staff. They hold a higher level of qualification than the general 2500 ValBy European pharmacy technician, more comparable to that of a Bachelor’s degree. Denmark In the community pharmacies, pharmaconomists worked long hours and faced [email protected] new questions and a change in behaviour by the public due to the pandemic. An emergency agreement Between The Danish Association of Pharmaconomists and the Association of Danish Pharmacies made flexible planning possible, and guidelines with recommendations meant that most community pharmacies ended up introducing safety measures. In hospitals, pharmaconomists were directly engaged in deciding which kinds of medicine to stock up on to help the COVID-19 patients as they were admitted to hospital. A high level of cooperation and the slashing of red tape made things run relatively smooth. The training of pharmaconomist students went online in spring of 2020, as did exams. It required planning, as did the return to physical school activities as well as CPE in the autumn of 2020.
    [Show full text]
  • Denmark V2 2012 2 the “PHARMINE Survey of European Higher Education Institutions Delivering Pharmacy Education & Training – DENMARK” Was Produced By
    Pharmacy education & training in DDEENNMMAARRKK 22001122 –– VVeerrssiioonn 22 . PHARMINE (PHARMacy education IN Europe) is a project funded by the European Commission (LLL programme, Erasmus). Its aims and objectives are to survey the present state of pharmacy education and training in Europe, and on the basis of this survey, formulate recommendations for new competence curricula for pharmacy education and training in the EU. A model for pharmacy ieducation and training for candidate member states and other countries will be proposed. The opportunities for a quality assurance and accreditation scheme for EU pharmacy courses will be investigated. PHARMINE will take into account two important issues, (i) the EU directive 2005/36/EC on the recognition of professional qualifications and, (ii) the Bologna declaration. PHARMINE will focus both on recommendations for core education and training and for activities such as industrial and hospital pharmacy. The PHARMINE consortium consists of universities which are members of the European Association of Faculties of Pharmacy (EAFP) and EU partner associations representing community, hospital of industrial pharmacy, together with the European Pharmacy Students’ Association and other interested bodies. In order to reach the objectives of the PHARMINE project, a work-plan was set up and divided into 7 work- packages (WP). The aims and objectives of PHARMINE WP7 are to: 1. Survey European higher education institutions (HEIs) 2. Produce a databank of pharmacy education and training courses in Europe leading to core pharmacist qualifications and to qualifications required for industrial and hospital pharmacy 3. Survey to what extent the “Bologna” (based on the principles enumerated in the Bologna declaration) and the “Sectoral profession” (based on 2005/36/EC) models for pharmacy education and training are compatible.
    [Show full text]
  • Public Health and Patient Care Aspects in Pharmacy Education and Pharmacists’ Role in National Public Health Programs in India
    Clinical Pharmacy Group: Social Pharmacy Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy University of Helsinki Public Health and Patient Care Aspects in Pharmacy Education and Pharmacists’ Role in National Public Health Programs in India Siva Prasada Reddy Maddirala Venkata ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Pharmacy of the University of Helsinki, for public examination in Auditorium Athena, Siltavuorenpenger 3 A, on Friday 19 May 2017, at 12 noon. Helsinki 2017 Supervisors Professor Marja Airaksinen, PhD Clinical Pharmacy Group: Social Pharmacy Division of Pharmacology and Pharmacotherapy Faculty of Pharmacy, University of Helsinki Helsinki, Finland Proprietor Pharmacist Peter Kielgast, PhD Taastrup Pharmacy Taastrup Hovedgade 60 2630 Taastrup, Denmark Pre-examiners Professor B. Suresh Vice-Chancellor, Jagadguru Sri Shivarathreeshwara University and President, Pharmacy Council of India JSS Medical Institutions Campus Sri Shivarathreeshwara Nagara Mysuru – 570 015, Karnataka, India Dr. T. V. Narayana Director, Vikas Institute of Pharmaceutical Sciences Nidigatla village, Korukonda Mandal, Near Airport Rajahmundry, East Godavari Dist Andhra Pradesh – 533103, India Opponent Fernando Fernandez-Llimos, Ph.D., PharmD., M.B.A. Assistant Professor, Department of Social Pharmacy University of Lisbon, Portugal © Siva Prasada Reddy Maddirala Venkata 2017 ISBN 978-951-51-3169-0 (paperback) ISBN 978-951-51-3170-6 (PDF) Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis Helsinkiensis ISSN 2342-3161 (print) ISSN 2342-317x (online) University of Helsinki, Finland 2017 ABSTRACT Pharmacies are convenient for most people to get to and there is no need for an appointment to see pharmacist which makes them natural first port of call1 healthcare providers in the society.
    [Show full text]